Navigation Links
CareFusion Reports First Quarter Fiscal 2012 Results
Date:11/7/2011

h and Development Expenses40--40Restructuring and Acquisition Integration Charges 22-(22)-Operating Income79-39118Interest Expense and Other, Net 23--23Income Before Income Tax56-3995Provision for Income Taxes20-1131Income from Continuing Operations36-2864Income from Discontinued Operations, Net of Tax2(2)---Net Income

$

38

$

(2)

$

28

$

64.Per Share Amounts:(4)Basic Earnings per Common Share

$

0.17

$

(0.01)

$

0.13

$

0.29Diluted Earnings per Common Share

$

0.17

$

(0.01)

$

0.13

$

0.29Weighted-Average Number of Common Shares Outstanding:Basic222.1222.1222.1222.1Diluted223.9223.9223.9223.9Effective Tax Rate34.4%n/a27.8%31.7%____________1Reflects the impact of the divestiture of the International Surgical Products (ISP) business.  The ISP business was divested in April 2011, and has been classified as discontinued operations. 2Reflects nonrecurring charges primarily related to the spinoff, nonrecurring restructuring and acquisition integration charges, and nonrecurring tax items.  3Adjusted financial information reflects GAAP results adjusted on a non-GAAP basis to exclude nonrecurring items noted.4Earnings per share calculations are performed separately for each adjustment presented.  Therefore, the sum of the per share adjustments from the table above may not equal the adjusted per share totals presented. CAREFUSION CORPORATIONADJUSTED SEGMENT FINANCIAL INFORMATION(UNAUDITED)Quarter Ended September 30, 2011Nonrecurring(in millions)GAAP Items(1)Adjusted(3)Medical SystemsRevenue$

509

$

-

$

509Operating Income $

88

$

7

$

95Procedural SolutionsRevenue$

335

$

-

$

335Operating Income $

20

$

4

$

24Quarter Ended September 30, 2010No
'/>"/>

SOURCE CareFusion
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation
2. Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011
3. InterMune Reports Third Quarter 2011 Financial Results and Business Highlights
4. Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results
6. Caliper Life Sciences Reports Third Quarter 2011 Results
7. Neurocrine Biosciences Reports Third Quarter 2011 Results
8. United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
9. Sangamo BioSciences Reports Third Quarter 2011 Financial Results
10. Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
11. ReportsnReports: Depression Therapeutics Market to Reach $10.9 Billion by 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... -- Pfenex Inc. (NYSE MKT: PFNX) announced today that its ... Thursday, August 13, 2015, before the open of market.  ... a conference call to discuss the financial results and ... financial results and business update will be publicly distributed ... (US) or 1-412-542-4131 (international) and reference Pfenex to access ...
(Date:7/29/2015)... ... 2015 , ... The third Medical Innovation Impact Index (MI3) Alert considers FDA ... combinations. The current system received a score of 0 (range -10 to +10) for ... of Fairleigh Dickinson University’s ( FDU ) Rothman Institute of Innovation and Entrepreneurship. ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... it has selected an optimized Erk inhibitor molecule ... the development of a new class of potential ... represents a prime target for therapeutic intervention in ... and survival benefits for B-Raf and Mek inhibitors. ...
(Date:7/29/2015)... Bruno, CA. (PRWEB) , ... July 29, 2015 ... ... agreement with PRC Clinical, a Silicon Valley-based CRO specializing in Clinical ... advisory services, and patient recruitment services. The core expertise of PRC Clinical is ...
Breaking Biology Technology:Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3
... new "gold standard" in the sensitivity of weighing scales. ... world,s first fully functional nanotube radio, researchers with Berkeley ... have fashioned a nanoelectromechanical system (NEMS) that can function ... of a single atom of gold. , Alex Zettl, ...
... Inc. (NYSE: MYL ),today announced that its ... the U.S. Food and Drug Administration (FDA),for its ... Tablets, 20 mg, 30 mg and 40 mg., ... of hypertension,are the generic version of Sciele Pharma,s ...
... Fred Alger Management, Inc. (Alger),a leading asset management ... as Vice President, Senior Analyst/Co-Portfolio Manager for,Alger covering ... industries., David received his Doctor of Medicine ... Chief Medical Resident. While in Pennsylvania David,served as ...
Cached Biology Technology:Golden scales 2Golden scales 3David Farhadi, M.D. to Join Alger as Vice President, Senior Analyst/Co-Portfolio Manager 2
(Date:7/21/2015)... , July 21, 2015 Today, ZTE ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... FPC1 02 5 for Axon , ...
(Date:7/13/2015)... 13, 2015 Synaptics Inc. (NASDAQ: ... solutions, today announced sampling of ClearPad ® ... integration (TDDI) product targeting smartphones and tablets. This ... Synaptics , best-in-class touch controller IP and ... developed in the company,s Japan Design Center. TDDI ...
(Date:7/9/2015)... July 9, 2015  Unchained Labs just can,t ... acquisition of Avid Nano. Avid Nano designs, develops ... systems.    Also today, Unchained Labs ... easiest to use protein sizing system. The pUNk ... protein,s hydrodynamic size, size distribution, aggregation population and ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... Farrow and Zafer Iqbal, research professors at NJIT, were ... fabricating arrays of nanoscale electrical probes. Their discovery ... spatial variation of electrical activity inside biological cells. ... array technique that allows for an array of individual, ...
... Missouri officials announced today a $5 million grant agreement ... Translational Partnership Award Program. The goal of the partnership ... improve patient lives and suffering from any disease or ... will be used to support collaborative projects between biomedical ...
... assessment, written by WCS Senior Conservation Scientist Dr. John ... information on these species and how climate change ... region and from nearly 300 scientific papers. In ... through these remote roadless areas to evaluate their importance ...
Cached Biology News:Patent for arrays of nanoscale electrical probes awarded to NJIT today 2MU signs $5 million agreement with Coulter Translational Research Partnership Program 2MU signs $5 million agreement with Coulter Translational Research Partnership Program 3Where will grizzly bears roam? 2
... leading provider of X-ray crystallography services ... screening services to its pharmaceutical and ... binding of drug-like fragments to the ... targets, allowing scientists to develop novel, ...
...
... (AChE) activity. This is a highly sensitive, ... and easy to use assay for AChE ... A series of coupled enzyme reactions translates ... change in luminescence. Inhibitors of AChE are ...
Rabbit polyclonal to Vitronectin ( Abpromise for all tested applications). Antigen: Full length native Vitronectin (Cow) Entrez Gene ID: 7448 Swiss Protein ID: P04004...
Biology Products: